Top 5 Health Care VC Funds in Latvia

Last updated: Apr 2024 A list of 5 VC funds that invest in Health care startups based in Latvia. We rank investors based on the number of investments they made in Health care companies from Latvia. We update this investor list every month.

Top 5 Health Care VC Funds in Latvia

Investor	Health Care Latvia investments
FlyCap	3
Qiming Venture Partners USA	2
Abingworth	2
ZGI Capital	2
TSVC	1

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

FlyCap AIF is a Venture Capital Fund of total size of 15.75 MEUR. The Fund provides growth capital for Latvia based SME’s in a form of investments in equity and mezzanine capital.

Investment focus

Health Care, Consumer Goods, Medical
Funding Round, Seed, Debt Financing
Latvia, Estonia, The Netherlands

Portfolio highlights

Tapcore — Tapcore is the only solution on the market that enables mobile developers to monetize pirated copies of their apps through advertising. Established in 2015, we are a remote company with headquarters in the Netherlands. Currently we serve over 150 million ad requests daily (and counting!).
Purified — Purified is a nutritional supplement supplier.. It offers black chocolate produced by the best doctors in collaboration with scientists.
Elmo — In our car sharing business Elmo Rent we wanted to serve maximum customers with minimum resources, so we created remote control technology to deliver vehicles.

Qiming Venture Partners invests in young, fast-growing companies across China in the media and internet, IT, consumer and retail, healthcare, and clean technology sectors. we are early to growth stage venture capital firm with offices in Shanghai, Beijing and Hong Kong. Since their debut in 2006, we have established their selves as a leadinginvestment firm in China and currently manage four funds with over $1 billion in assets.

Investment focus

Biotechnology, Health Care, Pharmaceutical
Series A, Series B, Seed
United States, China, Canada

Portfolio highlights

Tourmaline Bio — Tourmaline Bio is a clinical biotechnology company developing transformative medicines to dramatically improve the lives of patients and prevent immune diseases.
Jasper Therapeutics — Jasper is a biotechnology company focused on enabling safer conditioning agents to allow for expanded use of curative therapy with stem cell transplants and gene therapies. Jasper’s lead compound, JSP191, is in clinical development as a conditioning antibody that clears hematopoietic stem cells from bone marrow in patients undergoing a stem celltransplant.
Tenpoint Therapeutics — Tenpoint Therapeutics is a biotechnology company pursuing vision-restoring engineered cell-based therapeutics.

We are Abingworth, a trans-atlantic bio-science investment firm with a deep understanding of both the science and markets we invest in.

Investment focus

Biotechnology, Health Care, Pharmaceutical
Series B, Series A, Series C
United States, United Kingdom, France

Portfolio highlights

Q32 Bio — Q32 Bio is developing drugs targeting powerful regulators of both the innate and adaptive immune systems with the goal of re-balancing the immune system.
Gilead Sciences — Gilead Sciences, Inc. is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicines.
Jasper Therapeutics — Jasper is a biotechnology company focused on enabling safer conditioning agents to allow for expanded use of curative therapy with stem cell transplants and gene therapies. Jasper’s lead compound, JSP191, is in clinical development as a conditioning antibody that clears hematopoietic stem cells from bone marrow in patients undergoing a stem celltransplant.

ZGI Capital is the fund management company that manages "ZGI fund”, that was founded to support entrepreneurs lacking start-up capital for their business. The total amount of assets available for venture capital investments is of EUR 7.4M. Combined with bank financing, this will allow to finance investment projects with total assets of up toEUR 30M. The fund acts on behalf of various investors including the State.